FDA recall, , Moderate risk
Rhode Island Blood Center Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were collected from a donor in a malaria endemic area.
Recall ended Aug 5, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Rhode Island Blood Center, A Division of New York Blood Center, Inc., began a recall of Red Blood Cells, Leukocytes Reduced on February 19, 2026. The FDA added the recall to its Enforcement Report on August 5, 2026, and listed it in the weekly enforcement report on August 12, 2026. The product, collected from a donor who was a resident of a malaria endemic area, was distributed in Rhode Island.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Rhode Island Blood Center, A Division of New York Blood Center, Inc.
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99398
- Recall number
- B-0155-2026
All recalls from Rhode Island Blood Center, A Division of New York Blood Center, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
